Clinical Trial

Optimizing Parameters of Transcranial Temporal Interference Stimulation for Spinocerebellar Ataxia Type 3

Name: Optimizing Parameters of Transcranial Temporal Interference Stimulation for Spinocerebellar Ataxia Type 3 — clinical trial record (NCT07743866)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Not Yet Recruiting

View on ClinicalTrials.gov →

Summary

The purpose of this research study is to identify the optimal biological dose for tTIS that targets DN in SCA3 while achieving the best possible balance between therapeutic efficacy and safety.

Trial Details

NCT Number	NCT07743866
Lead Sponsor	First Affiliated Hospital of Fujian Medical University
Conditions	Spinocerebellar Ataxia Type 3
Enrollment	24 participants
Start Date	2026-08-07
Primary Completion	2026-11-30 (estimated)
Study Completion	2027-02-28 (estimated)
Updated on ClinicalTrials.gov	2026-08-05